Configurationally restricted bismacrocyclic CXCR4 receptor antagonists
Gina C Valks1, Graeme McRobbie, Elizabeth A Lewis
1Department of Chemistry and Clinical Biosciences Institute, University of Hull, Hull, HU6 7RX, United Kingdom.
Abstract:
A zinc(II) containing configurationally restricted analogue of bismacrocyclic cyclam-type CXCR4 chemokine receptor antagonists has been synthesized and shown to adopt only one configuration in solution. The single crystal X-ray structure reveals favorable binding to acetate via a bidentate chelation that can be related to the proposed interaction with aspartate on the receptor protein surface. The zinc(II) complex is highly active against HIV infection in vitro.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
Related Concept Videos
Antifungal Agents
GPCRs Regulate Adenylyl Cylase Activity
Two...
Inhibition of Cdk Activity
Cycloaddition Reactions: MO Requirements for Thermal Activation
The Antiviral System of Bacteria and Archaea: CRISPR
Antiviral Nucleoside Inhibitors
